It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
WASHINGTON (Reuters) - When advisers to the U.S. Food and Drug Administration met to discuss a new vaccine against H1N1 swine flu last week, some of the biggest critics of vaccination were not only in the room, but at the table.
The concerns:
*Will a vaccine against a swine-like virus cause more adverse reactions than a seasonal flu vaccine?
*Will special additives called adjuvants cause reactions?
*Will the vaccines contain thimerosal, a mercury-based preservative that critics say might cause problems?
*Is it dangerous to vaccinate against both seasonal flu and the new H1N1 flu at the same time?
Adjuvants are used in flu vaccines in Europe but not the United States and although it would be possible to get a U.S. license under Emergency Use Authorization, officials have chosen to use vaccines without it for now.
Companies such as Glaxo say they will be ready to start vaccinating people in Europe just as the first data from those trials start emerging at the end of September. Some have questioned this speed.
Originally posted by Iamonlyhuman
Well, at least we know that the FDA is listening to the concerns. What they do with them is the question. This could very well be a piece intent on establishing trust with the American citizens that the FDA is considering all the concerns people have, but they do seem to have some of the right people involved.
www.reuters.com...
WASHINGTON (Reuters) - When advisers to the U.S. Food and Drug Administration met to discuss a new vaccine against H1N1 swine flu last week, some of the biggest critics of vaccination were not only in the room, but at the table.
The concerns:
*Will a vaccine against a swine-like virus cause more adverse reactions than a seasonal flu vaccine?
*Will special additives called adjuvants cause reactions?
*Will the vaccines contain thimerosal, a mercury-based preservative that critics say might cause problems?
*Is it dangerous to vaccinate against both seasonal flu and the new H1N1 flu at the same time?
Adjuvants are used in flu vaccines in Europe but not the United States and although it would be possible to get a U.S. license under Emergency Use Authorization, officials have chosen to use vaccines without it for now.
Companies such as Glaxo say they will be ready to start vaccinating people in Europe just as the first data from those trials start emerging at the end of September. Some have questioned this speed.